All Summit attendees are invited to a reception to celebrate the opening of the 15th annual Medical Innovation Summit. Come to the 5th floor of the Hilton and enjoy drinks, hors d’oeuvres, and a view of beautiful Lake Erie.
Hilton Downtown Cleveland
Veterans Ballroom - 5th Floor
Don’t miss a chance to hear from a variety of Health IT companies positioned to solve some of healthcare’s biggest challenges. Join our panel of experts in voting for the next winner of The Challenge.
Enjoy a prepared lunch in Exhibit Hall A while visiting with our Summit sponsors.
Some of the nation's leading healthcare executives examine recent policy impacts, cost reduction strategies, medical innovation funding and the overall health of medical research and innovation in the U.S.
While genomics may hold the keys to managing and eliminating some of the most debilitating diseases, the fact of the matter is that genomic testing is expensive. Experts on this panel will discuss the nuances of this roadblock and what payers, providers, innovators – or even the government – can do to overcome it.
Precision medicine is making its debut at a peculiar time. While hospitals are working to maintain costs, and insurance companies are working to protect profitability, the clinical potential of genomic medicine is impossible to ignore. Experts on this panel will cover these market dynamics, explain why they have invested in genomics, and how they are evaluating the companies that are boldly venturing into uncharted markets.
Kick off the first official evening of MIS2017 with a reception honoring our Summit Sponsors.
Exhibit Hall A
Consumers are showing more interest than ever in their ancestry and genetic makeup. Panelists will discuss this new consumer market, and how these new services will integrate with health systems and primary care physicians.
Additional Details Coming Soon.
Additional Details Coming Soon.
Just 17 years ago, the human genome was first sequenced at a price of $300 million. Today, companies are furiously trying to get this down to a hundred bucks per sequence. Panelists will discuss the latest attempts, the current challenges, and the timeline for bringing the genome into every doctor’s office.
In a new era of value-based technology, the need to demonstrate outcomes is becoming critical. The medical device industry in particular is showing signs of abandoning its one-size-fits-all mentality in favor of a hyper-precise methodology that accounts for the unique needs of the individual. This panel will discuss how the biggest players in the industry are investing in this new market, and give a glimpse of some novel technologies that are leading this new charge.
Zeroing In on Disease: The Latest Tools in Risk Stratification and Early Detection
AI Update: Using Personal Data to Make Clinical Decisions
Complete Picture: The Clinical & Commercial Promise of Image-Enabled Precision Medicine
The patient journey is changing. Rather than waiting for a disease to take hold to get help, genetic tests can indicate the tiniest of breadcrumbs that will lead to disease. Experts will discuss the business opportunities for these tests, and how they can inform the earliest of treatment.
While genomics and precision medicine offer so much hope for patient care, how can clinicians be expected to make definitive sense of all the data? Panelists will discuss the latest AI and Decision Support technologies that can help clinicians avoid information overload.
In medicine, a picture is worth a lot more than a thousand words. Clinicians are using images to find new markers that can guide treatment decisions, as well as guide surgery in real-time. This panel will discuss some of the latest technologies, opportunities, and challenges to be overcome in image-based precision medicine.
Gut Reaction: Harnessing the Potential of the Microbiome
Changing Fate: Engaging with At-Risk Populations
Orthopaedics 2020: A Market Analysis of Customized Surgeries
When it comes to life-saving potential and market opportunities, it turns out the gut is a gold mine. The trillions of bacteria making up communities in our body, referred to as the microbiome, are unlocking mysteries at an incredible pace. Experts on this panel will make sense of a market that is aligning and realigning to keep up with the endless possibilities.
One of the most common questions following a genetic test from patients is “Now What?” Panelists will discuss the options available to patients that have a high likelihood of contracting an illness. They will also look at companies that are responding to this new population of patients.
The orthopaedic field has taken a leading role in making value-based care work for all stakeholders. Experts on this panel will discuss how tailoring orthopaedic surgery holds the promise of promoting a healthier system, business, and patient.
More Science, Less Art: An Industry Perspective on Pharmacogenomics
Knowing Too Much? Legal & Financial Implications of Obtaining your Blueprint
Made-to-Order Organs: How 3D Printing is Revolutionizing Surgery
Patients might be a little surprised to learn how little physicians and scientists know how drugs work, let alone whether they will work or not work for certain patients. For many neurological diseases, for example, physicians have little choice but to use trial and error until the patient reports improvement. Pharmacogenomics is changing this as we speak. Experts on this panel will discuss the tremendous strides in using genomics to predict how patients will respond to medications. They will also attempt to answer the inevitable question: who is going to pay for it?
Given the enormous possibilities for avoiding disease, why wouldn’t consumers want their genome sequenced? Well for one, there will be many organizations that will want to know that information, especially insurance companies. Panelists will describe the changing insurance landscape, and what needs to be done so innovators, clinicians, patients, and payers are all on the same page.
It wasn’t long ago that the concept of holding an anatomically correct model of your own heart in your hand was foreign. Today, surgeons are beginning to order exact replicas of patient organs to plan and practice the most precise procedures. Experts on this panel will discuss the clinical and market expectations for taking surgical planning to a new level.
Feeding your Genes: The Business and Science of Nutrigenomics
Ideation Lab: Three Ethical Quandaries
Frame of Mind: Precision Medicine Meets the Neurosciences
Why do some diets work for some and not others? Some say the answer lies in our genes. Experts on this panel will sort through the hype and the science of nutrigenomics.
It’s impossible to discuss genomics and precision medicine without discussing ethics. Experts will facilitate an exchange of ideas between all attendees regarding the ethics of CRISPR, Cloning, and Genetic Engineering.
Neurological diseases have a growing arsenal of potential therapies, ranging from drugs and rehab to deep brain stimulation. In order to make the most informed decisions, neurologists everywhere are taking a closer look at the individual patient. Experts on this panel will discuss the latest techniques, and the market opportunities for personalizing neuro therapies.
We are already navigating a sea of big data. Yet, if researchers get their wish of sequencing a million genomes in the next few years, one thing is clear: we’re gonna need a bigger boat. Panelists will discuss the latest in cloud computing and analytics.
Turns out gene editing is cheap and pretty simple. Within 2 years of its discovery, CRISPR is already in labs everywhere. It’s also been used to treat diseases, and may even be the key to curing some types of leukemia. Experts on this panel will look at the tremendous business opportunity for CRISPR, while also looking at what this all means for humanity, answering the question: Is it a little too easy?
Is gene therapy making a comeback? After a rocky debut in the last decade, the industry is showing cautious optimism based on recent progress for diseases like sickle cell anemia and metabolic disorders. Panelists will discuss the lessons learned and what patients, doctors, and the market can expect from gene therapy in the coming years.
Cleveland Clinic’s Top 10 list of breakthrough technologies for the coming year has become an international sensation.
Cvent Online Event Registration Software | Copyright © 2000-2017 Cvent, Inc. All rights reserved.